Research exhibits possible earlier detection for mesothelioma cancer malignancy identified through mesothelin levels

A new blood marker was found for mesothelioma by the National Research Centre for Asbestos Associated Sickness, School of Medicine and Pharmacology at the University of Western Australia. Researchers observed that the degree of soluble mesothelin-linked protein (SMRP), also acknowledged as serum mesothelin, was elevated in mesothelioma victims and this could lead to an early detection of the asbestos-associated cancer malignancy.Mesothelin occurs generally on mesothelial tissues and other most

Mesothelioma